Events

AMTA Conference 2000

American Methadone Treatment
Association
April 9-12, 2000
San Francisco


Preconference Meeting

How Can We Develop and
Strengthen Patient Advocacy Groups?

Day: Sunday
Date: April 9, 2000
Time: 1 – 5 PM

Moderator: John Finger, TexNAMA
Presenters:
Joycelyn Woods, NAMA
Diane Fleury-Seaman, MALTA
Fred Christie, AFIRM
James DePasquale, Membership Director/Chapter Coordinator of NAMA

.

This special preconference meeting has been developed by the
National Alliance of Methadone Advocates (NAMA) in collaboration with other
advocacy groups to present concepts that programs can use to promote positive
patient outcomes and consumer satisfaction that will be a major focus for the
new accreditation system. Ways for providers to develop consumer satisfaction
including patient recognition ceremonies, 12 step groups, patient advisory
boards, patient advocacy groups and patient organizing drives are some of the
strategies that can be utilized by providers and patients to work together. The intended audience for this
presentation includes program directors, medical personnel, doctors, nurses,
counselors, social workers, administrative staff, patients, advocates and anyone
else interested in the methadone field. This meeting will greatly enhance the
ability of providers and patients to become one community with the common goal
of creating the best methadone system possible.

Supported by the Center for Substance Abuse Treatment


Conference Workshops

 

 

Planting Seeds and Watching Patients Grow

Day: Tuesday
Date: April 11 2000
Time: 1 – 2:30 PM

Presenters:
Alice Diorio
New England Chapter/National Alliance of Methadone Advocates (NENAMA)
Diane Fleury-Seaman, S.D.C.
Methadone as a Legitimate Treatment Alternative (MALTA)
John McCarthy, M.D.
Bi-Valley Medical Clinic (NAMA Advisory Board)

This interactive workshop uses harm reduction principles and
sensitivity training to improve outcomes. Presenters will give a patient’s
perspective on how to create individualized treatment based on communication and
respect. They will discuss ways to enhance a trusting, therapeutic relationship
that conveys compassion and understanding.

Visit NAMA’s AMTA Conference 2000 Committee
Committee Chair John
Finger

Visit the AMTA website at www.assnmethworks.org


3rd National Harm Reduction
Conference

Harm Reduction Coalition
October 21-25, 2000
Miami

Preconference Meeting

3rd National Methadone Consumers
Meeting

Day and Time: To be determined.

Meeting sponsored by NAMA, MALTA and Miami/Florida NAMA.

Committee Chair:Carlos
Franco

Methadone Enabler
Florida/Miami NAMA

Visit the HRC website at www.harmreduction.org


11th International Conference on the
Reduction of Drug Related Harm

April 9-13, 2000
Jersey Channel Islands, British Isles

NAMA will not be attending this conference however many of our
international affiliates will be participating in the conference and the Users
Meeting held during the conference and report back.


Back To Top

Similar Posts

  • |

    Internet Resources

    Admin 05/29/2021

    Treatment Facility Locator Buprenorphine Physician Locator Maintenance Assistance Point (Europe) Indro’s Coordinating and Information Resource Center for International Travel Traveler’s Health Kit Office of National Drug Control Policy Center For Substance Abuse Treatment CSAT Patient Support & Community Education Project Program Version (PDF Format) National Clearinghouse Opioid Drugs in Maintenance and Detoxification Treatment of Opiate…

  • Methadone Medical Maintenance

    Admin 10/22/2022

    Policy Statement Number 1 April 1994 The National Alliance of Methadone Advocates supports the concept of Medical Maintenance and the prescribing of methadone outside of the methadone clinic setting. Medical Maintenance was initially implemented for patients who had achieved a high level of functionally in society and were hindered by the regulations that were conceived…

  • |

    OBOT Publications

    Admin 04/20/2023

    Publications Office Based Opioid Treatment Federal Code U.S. Federal Code. Confidentiality of Alcohol and Drug Abuse Patient Records. U.S. Federal Code. Medical Privacy HIPPA, National Standards to Protect the Privacy of Personal Health Information. Public Law 106-310, 106th Congress Sec. 3502. Controlled Substances Act, October 17, 2000. Physician Waiver to Prescribe, Dispense Schedule III-V Narcotic Drugs in the…

  • Methadone Advocacy

    Admin 04/11/2021

      The National Alliance of Methadone Advocates (nama) holds the view that every individual who believes in methadone treatment is at least a potential Certified Methadone Advocate (CMA). We encourage all supporters of methadone treatment, patient and non-patient, to become Certified Methadone Advocates so that all energies directed toward the advancement of methadone treatment produce…